Gene · 7305
Papers3,266
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,266
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Pathogenesis in Alzheimer's Disease: TREM2 as a Potential Target. | J Integr Neurosci | 2023 | 38176932 | PubTator, text mining | PubMed |
| Synergistic treatment strategy: combining CAR-NK cell therapy and radiotherapy to combat solid tumors. | Front Immunol | 2023 | 38162672 | PubTator, text mining | PubMed |
| The role of immune checkpoints in antitumor response: a potential antitumor immunotherapy. | Front Immunol | 2023 | 38162657 | PubTator, text mining | PubMed |
Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma. | Front Immunol | 2023 | 38162649 | PubTator, text mining | PubMed |
| CAR-T cell immunotherapy for ovarian cancer: hushing the silent killer. | Front Immunol | 2023 | 38146364 | PubTator, text mining | PubMed |
| The Role of NKG2D and Its Ligands in Autoimmune Diseases: New Targets for Immunotherapy. | Int J Mol Sci | 2023 | 38139373 | PubTator, text mining | PubMed |
| SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity. | Int J Mol Sci | 2023 | 38138970 | PubTator, text mining | PubMed |
| Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer's Disease. | Biomedicines | 2023 | 38137453 | PubTator, text mining | PubMed |
| Microglial Senescence and Activation in Healthy Aging and Alzheimer's Disease: Systematic Review and Neuropathological Scoring. | Cells | 2023 | 38132144 | PubTator, text mining | PubMed |
| Identification of driver genes in lupus nephritis based on comprehensive bioinformatics and machine learning. | Front Immunol | 2023 | 38130724 | PubTator, text mining | PubMed |
| The role of CD47 in non-neoplastic diseases. | Heliyon | 2023 | 38125492 | PubTator, text mining | PubMed |
| Signal regulatory protein beta 2 is a novel positive regulator of innate anticancer immunity. | Front Immunol | 2023 | 38116002 | PubTator, text mining | PubMed |
| Role of the immune system in liver transplantation and its implications for therapeutic interventions. | MedComm (2020) | 2023 | 38098611 | PubTator, text mining | PubMed |
| Advancing CART therapy for acute myeloid leukemia: recent breakthroughs and strategies for future development. | Front Immunol | 2023 | 38098489 | PubTator, text mining | PubMed |
| Cell Type Catalog of Middle Turbinate Epithelium (Cell Catalog of Turbinate Epithelium). | OTO Open | 2023 | 38093720 | PubTator, text mining | PubMed |
| Killer instincts: natural killer cells as multifactorial cancer immunotherapy. | Front Immunol | 2023 | 38090565 | PubTator, text mining | PubMed |
| A pilot study on the immune cell proteome of long COVID patients shows changes to physiological pathways similar to those in myalgic encephalomyelitis/chronic fatigue syndrome. | Sci Rep | 2023 | 38086949 | PubTator, text mining | PubMed |
| Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma. | BMJ Open Respir Res | 2023 | 38081768 | PubTator, text mining | PubMed |
| The effects of semaphorin 3A in bone and cartilage metabolism: fundamental mechanism and clinical potential. | Front Cell Dev Biol | 2023 | 38078001 | PubTator, text mining | PubMed |
| Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis. | Front Immunol | 2023 | 38077334 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7305/papers?page=12